MDT treatment planning – General
Discuss all cases of breast cancer within a multidisciplinary team (MDT) treatment planning meeting at least once, and ideally before any treatment, including surgery, is initiated so that a treatment plan can be recommended that takes account of patient comorbidities and includes consideration for neoadjuvant systemic therapy. If possible, results of all relevant tests and imaging should be available for the MDT discussion. Consider a follow-up discussion if there is significant change in the course of the disease after commencement of therapy.
All cases of breast cancer should be discussed within a multidisciplinary team before any treatment is initiated
Useful Links
How this guidance was developed
No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. The practice point was developed using an expert consensus process. The practice was informed by a source recommendation in the KCE 2013 guidelines (Belgium) that was designated as ‘Expert Opinion’.
MDT treatment planning – General
Discuss all cases of breast cancer within a multidisciplinary team (MDT) treatment planning meeting at least once, and ideally before any treatment, including surgery, is initiated so that a treatment plan can be recommended that takes account of patient comorbidities and includes consideration for neoadjuvant systemic therapy. If possible, results of all relevant tests and imaging should be available for the MDT discussion. Consider a follow-up discussion if there is significant change in the course of the disease after commencement of therapy.
Useful Links
No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. The practice point was developed using an expert consensus process. The practice was informed by a source recommendation in the KCE 2013 guidelines (Belgium) that was designated as ‘Expert Opinion’.